Saint Vincent Hospital is a 381-bed hospital located in Worcester, Massachusetts. Founded by the Catholic Sisters of Providence of Holyoke in 1893, Saint Vincent's was named after the patron saint of the Sisters' order, Saint Vincent de Paul. In 1990, the hospital merged with the Fallon Healthcare System.

During the past decade, St. Vincent Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 8 clinical trials were completed, i.e. on average, 88.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Vincent Hospital" #1 sponsor was "Massachusetts General Hospital" with 4 trials, followed by "Beth Israel Deaconess Medical Center" with 3 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored, "Abiomed Inc." with 1 trials sponsored and "Agendia" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Vincent Hospital" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Agency for Healthcare Research and Quality (AHRQ)" with 1 trials as a collaborator, "Albany Stratton VA Medical Center" with 1 trials as a collaborator and "Baxter Healthcare Corporation" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "St. Vincent Hospital" are "Septic Shock" (4 trials), "Acute Respiratory Distress Syndrome" (2 trials), "Breast Cancer" (2 trials), "Cardiovascular Diseases" (2 trials) and "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "St. Vincent Hospital" in a lesser frequency.

Most popular intervention types in "St. Vincent Hospital" are "Drug" (11 trials), "Device" (3 trials), "Other" (3 trials), "Diagnostic Test" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "ABIOMED, Inc. hemodynamic support devices" (1 trials), "CMX-2043" (1 trials), "Cisatracurium Besylate" (1 trials) and "Early Fluids" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Vincent Hospital" are 19 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "St. Vincent Hospital". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in St. Vincent Hospital, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St. Vincent Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".